· 2 weeks ago

The Daily Brief: Knife Capital invests in PharmaScout, and more

PharmaScout

South African pharmaceutical temperature monitoring solution, PharmaScout, has secured Series A funding from Knife Capital while Nigerian agri-tech startup ThriveAgric is taking part in the 24th edition of the Silicon Valley-based 500 Startups accelerator programme. That and more in today’s brief.

Cairo-based AlMakinah and Global Shapers Giza to offer coding boot camp scholarships to Egyptian women

AlMakinah, a Cairo-based coding boot camp that helps people learn software development has teamed up once again with Global Shapers Giza Hub to launch the second edition of their female-focused program. MENAbytes.

South Africans develop new blockchain protocol

éMars is developing a mobile money platform and  protocol to  a new  targeting the African market. IT Web.

Vodacom, Telkom sign multi-billion-rand roaming agreement

Vodacom and Telkom have concluded a long-term, multi-billion-rand agreement whereby Telkom will obtain roaming and facilities leasing services from Vodacom with full effect from June 2019. IT Web.

Knife Capital invests in healthtech 5nines Technologies’ PharmaScout solution

SA venture capital (VC) fund Knife Capital announced today that it has made an undisclosed investment in Cape Town based healthtech firm 5nines Technologies to help grow its pharmaceutical temperature monitoring solution PharmaScout. Ventureburn.

Nigeria’s ThriveAgric selected for 500 Startups accelerator

Nigerian agri-tech startup ThriveAgric is taking part in the 24th edition of the Silicon Valley-based 500 Startups accelerator programme, which invests US$150,000 and offers hands-on training and mentorship. Disrupt Africa.

Zambia’s Z’POS is offering SMEs an alternative to POS machines

Founded in early 2017, Z’POS has the aim of enabling businesses in Zambia to manage their sales. The startup’s focus is small and medium-sized retail shops in all retail sectors. Think FMCGs, auto-spare shops, boutiques and the like. Digest Africa.

Subscribe to our newsletter to get the daily brief in your inbox.

VIEW ALL COMMENTS
0 Comments
Guest

Leave a Reply

Your email address will not be published. Required fields are marked *